Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,248 total articles
Micron sits squarely in the center of an industry structural squeeze. Memory shortages are limiting supply through 2028 even as hyperscalers and enterprise AI deployment ramp. Fundamentals - strong free cash flow, low leverage, and high ROE - support a buy-the-pullback approach. This is a swing trade: enter on a disciplined setup, target the next r…
AppLovin is entering Q2 2026 with momentum in revenue growth and margin expansion, driven by stronger adoption in e-commerce and a recently expanded self-serve stack. The stock is trading near $410 with attractive near-term technicals and an institutional narrative that still favors upside. This trade idea outlines a mid-term swing trade around the…
Rocket Lab looks operationally strong - growing revenue, a $2.2B backlog and fresh government contracts - but the planned $8B Iridium purchase and associated $3.6B bridge loan create a narrow path for a company that is unprofitable and burning cash. For traders who want a defined, time-boxed trade that bets on near-to-medium term dilution and finan…
PayPal is trading like a fading growth name despite generating meaningful free cash flow, a sub-11x P/E, and an enterprise value that implies significant downside protection. A $60.50 bid from Stripe/Advent and a board that pushed back reveals the stock is trading below what a buyer has already offered. For investors willing to tolerate deal risk, …
Core Scientific's reported partnership with AMD, combined with accelerating colocation revenue and a $500M expandable financing package, turns an otherwise speculative blockchain miner into a high-upside AI infrastructure play. Valuation is stretched on headline multiples, but operational momentum and a credible path to higher-margin hosting underp…
Comcast (CMCSA) trades at cheap multiples relative to its cash flow and offers a 5.5%+ yield while management separates the higher-growth media assets into a standalone company. That combination sets up a mid-to-long-term trade: collect yield and wait for either operational re-rating or a successful NBCUniversal spinoff to unlock value. Entry at $2…
Lumentum (LITE) sits at the center of the AI infrastructure supply chain. Recent headlines tying the company to Nvidia investments and multibillion-dollar purchase commitments, plus strong tape action and high short interest, set up an asymmetric trade: enter at $760, stop at $608, target $1,444 over a long-term (180 trading days) horizon. This is …
Schr dinger blends commercial simulation software with an in-house drug discovery pipeline. At roughly $1.14B market cap and an EV/Sales of ~3.4x on 2025 revenue of ~$256M, the company looks underpriced for a software-led growth story in the emerging AI drug discovery market. This trade idea outlines an actionable long with entry, stop and target c…
Mercedes-Benz Group AG shares are trading above key moving averages while technical momentum and a high-but-declining short interest profile set up a mid-term swing. The market is focused on elevated launch costs for new models that are masking an improving earnings trajectory. This trade idea uses a disciplined entry, stop and target and assumes c…
Constellation Energy controls roughly 22 GW of operating nuclear capacity, has marquee hyperscaler contracts and a clean utility profile. At $274.49 and a market cap near $98.5B, the stock trades at mid-teens EV/EBITDA and a P/E under 25, leaving room for re-rating as nuclear demand accelerates. I rate CEG a Strong Buy with an entry at $274.49, sto…
Alto Ingredients is showing above-average earnings growth driven by better product mix, higher-margin essential ingredients and recent accretive M&A. At a market cap near $377M and a P/E around 13, shares look to offer a favorable risk-reward for a mid-term trade focused on margin realization and re-rating back toward the 52-week high.
Quanta Services ($PWR) is a market leader in grid modernization and data-center hookups with a nearly $48.5B backlog, robust free cash flow and a clean balance sheet. The stock has pulled back from its highs and the market has compressed the effective entry multiple relative to the run-up; the fundamental thesis - electrification, grid upgrades and…
General Motors is showing a clean rebound in profitability driven by internal combustion vehicle (ICE) pricing, lower warranty and EV transition costs, and dramatically improved free cash generation. At roughly $86-$88 a share the stock offers a high FCF yield and reasonable EV/EBITDA given guidance implying adjusted EBIT of $14-16 billion. This tr…
Wyndham Hotels & Resorts (WH) is a franchising-heavy hotel company trading near the low end of its 52-week range with a $0.43 quarterly dividend, $323M in free cash flow and an enterprise value of roughly $8.16B. With a P/E of about 27 and ROE above 40%, the stock offers income and upside while carrying meaningful leverage. This trade targets a mea…
CCC Intelligent Solutions (CCCS) just delivered a Q2 that appears to reaccelerate SaaS revenue growth and margins. The combination of recurring ARR-like revenue, expanding gross margins and an asset-light business model argues for upside as the market re-prices forward cash flow visibility. This trade idea lays out an entry, stop and target with a …
<p>Pentair reported a surprise Q2 sales collapse tied to roughly $170M of Pool-channel inventory destocking and immediately cut full-year guidance from modest growth to a 4-7% decline. The market reaction and follow-up legal inquiries suggest downside remains. This is a tactical short idea sized for traders willing to tolerate execution and event r…
<p>Fortum is being treated like a regulated Nordic utility today, but its asset mix and strategic focus give it the profile of a scarce clean-power platform. We lay out a trade to capture a re-rating over the next 180 trading days, with explicit entry, stop and target. This is a directional trade - not a buy-and-forget - driven by a series of near-…
Tenable (TENB) looks like a pragmatic buy on weakness. The security vendor recently cleared important federal certifications, announced a Cisco partnership, and is rolling out Tenable Hexa AI — all while trading at roughly $3.8B market cap with healthy free cash flow. Technicals show a neutral-to-firm setup after consolidation; I recommend entering…
Nvidia appears to be using corporate finance levers - buybacks, structured instruments and targeted capital deployment - to accelerate control over strategic AI infrastructure. That dynamic creates a near-term asymmetric trade: buy the stock on a tactical pullback with a tight stop and a mid-term target that captures conviction-driven multiple expa…
Boeing's production cadence is stabilizing and deliveries are accelerating. With fresh commercial leases, a multi-billion defense satellite award, and improving technical momentum, the risk/ reward favors a long exposure into the next 6 months. This is a trade idea — entry, stop, and target defined — built around improving fundamentals and a re-rat…
Micron is trading like a cyclical commodity stock in a panic while delivering exceptional profitability, cash flow and shareholder-friendly metrics. At $825, the company trades at ~18x trailing earnings with $26.2B in free cash flow and an enterprise value roughly in line with market cap. This trade idea upgrades Micron to a BUY with a clear entry,…
Proto Labs is moving from prototyping toward scalable production while trading off a modest premium. Strong free cash flow, recent product launches, and industry tailwinds support a long trade targeting meaningful upside over the next 180 trading days.
SK hynix is one of the handful of memory suppliers that can materially benefit from a shift to agentic AI workloads. We lay out a mid-term trade (45 trading days) to capture a likely re-rating driven by HBM adoption and server memory tightness, with clear entry, stop, and target levels and a balanced look at risks and catalysts.
Teva has already rallied sharply, but multiple compression looks incomplete. Improving profitability, a growing biosimilars franchise, and late-stage neuroscience assets (ecopipam) create a credible re-rating path. This trade targets a near-term re-test of the 52-week high while keeping a disciplined stop for downside protection.
Oracle's share price has been punished this summer amid heavy AI infrastructure spending and balance-sheet worries. The business remains cash-generative at the operating level, carries large remaining performance obligations, and trades below its historical operational multiple after the recent sell-off. This trade idea frames a disciplined long: e…
